{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:52:10Z","timestamp":1790373130480,"version":"4.1.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1001\/jamadermatol.2020.0290","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T11:01:36Z","timestamp":1584529296000},"page":"545","source":"Crossref","is-referenced-by-count":70,"title":["Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy"],"prefix":"10.1001","volume":"156","author":[{"given":"Claire","family":"Mignard","sequence":"first","affiliation":[{"name":"Centre de r\u00e9f\u00e9rence des maladies bulleuses auto-immunes, Department of Dermatology, Rouen University Hospital, Normandie University, INSERM U1234, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Maho-Vaillant","sequence":"additional","affiliation":[{"name":"Centre de r\u00e9f\u00e9rence des maladies bulleuses auto-immunes, Department of Dermatology, Rouen University Hospital, Normandie University, INSERM U1234, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Golinski","sequence":"additional","affiliation":[{"name":"Centre de r\u00e9f\u00e9rence des maladies bulleuses auto-immunes, Department of Dermatology, Rouen University Hospital, Normandie University, INSERM U1234, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Balay\u00e9","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Clinical Research, Rouen University Hospital, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Prost-Squarcioni","sequence":"additional","affiliation":[{"name":"Centre de r\u00e9f\u00e9rence des maladies bulleuses auto-immunes, Avicenne Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Department of Dermatology, University of Paris 13, Bobigny, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Houivet","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Clinical Research, Rouen University Hospital, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9\u00b4bastien","family":"Calbo","sequence":"additional","affiliation":[{"name":"Centre de r\u00e9f\u00e9rence des maladies bulleuses auto-immunes, Department of Dermatology, Rouen University Hospital, Normandie University, INSERM U1234, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Labeille","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Saint Etienne, Saint Etienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Picard-Dahan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Bichat Hospital, University of Paris X, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Polina","family":"Konstantinou","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Chaby","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Amiens, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Aleth","family":"Richard","sequence":"additional","affiliation":[{"name":"Assistance Publique des H\u00f4pitaux de Marseille, Department of Dermatology, Aix Marseille University, UMR 911, INSERM CRO2, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-David","family":"Bouaziz","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St Louis Hospital, Paris 7 Sorbonne Paris Cit\u00e9 University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Duvert-Lehembre","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Delaporte","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bernard","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Reims, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Caux","sequence":"additional","affiliation":[{"name":"Centre de r\u00e9f\u00e9rence des maladies bulleuses auto-immunes, Avicenne Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Department of Dermatology, University of Paris 13, Bobigny, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Alexandre","sequence":"additional","affiliation":[{"name":"Centre de r\u00e9f\u00e9rence des maladies bulleuses auto-immunes, Avicenne Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Department of Dermatology, University of Paris 13, Bobigny, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Ingen-Housz-Oro","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Assistance Publique\u2013H\u00f4pitaux de Paris, Henri Mondor Hospital, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vabres","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Dijon University Hospital, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Quereux","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Dupuy","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Rennes, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Debarbieux","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Centre Hospitalier Lyon Sud, Pierre B\u00e9nite, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Avenel-Audran","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"D\u2019Incan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Clermont-Ferrand, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"B\u00e9dane","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Limoges, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"B\u00e9n\u00e9ton","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Le Mans General Hospital, Le Mans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Jullien","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Edouard Herriot Hospital, Lyon Claude Bernard University, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dupin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Paris V, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Misery","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brest University Hospital, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Machet","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tours University Hospital, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Beylot-Barry","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dereure","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sassolas","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Brest University Hospital, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Benichou","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Clinical Research, Rouen University Hospital, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Joly","sequence":"additional","affiliation":[{"name":"Centre de r\u00e9f\u00e9rence des maladies bulleuses auto-immunes, Department of Dermatology, Rouen University Hospital, Normandie University, INSERM U1234, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"H\u00e9bert","sequence":"additional","affiliation":[{"name":"Centre de r\u00e9f\u00e9rence des maladies bulleuses auto-immunes, Department of Dermatology, Rouen University Hospital, Normandie University, INSERM U1234, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the French Study Group on Autoimmune Bullous Skin Diseases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"doi200010r1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(91)90360-B","article-title":"Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion.","volume":"67","author":"Amagai","year":"1991","journal-title":"Cell"},{"issue":"5","key":"doi200010r2","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1172\/JCI114036","article-title":"Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.","volume":"83","author":"Stanley","year":"1989","journal-title":"J Clin Invest"},{"issue":"20","key":"doi200010r3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease.","volume":"306","author":"Anhalt","year":"1982","journal-title":"N Engl J Med"},{"key":"doi200010r4","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris\u2014incidence and mortality in the UK: population based cohort study.","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"issue":"17","key":"doi200010r5","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMra061111","article-title":"Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome.","volume":"355","author":"Stanley","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"doi200010r6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/1523-1747.ep12613668","article-title":"Adhesion molecules, I: keratinocyte-keratinocyte interactions; cadherins and pemphigus.","volume":"104","author":"Amagai","year":"1995","journal-title":"J Invest Dermatol"},{"issue":"4","key":"doi200010r7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"issue":"3","key":"doi200010r8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-015-0353-6","article-title":"Pemphigus vulgaris: an evidence-based treatment update.","volume":"75","author":"Zhao","year":"2015","journal-title":"Drugs"},{"issue":"1","key":"doi200010r9","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus.","author":"Martin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"doi200010r10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jaad.2015.04.038","article-title":"The role of adjuvant therapy in pemphigus: a systematic review and meta-analysis.","volume":"73","author":"Atzmony","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi200010r11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/jdv.12772","article-title":"Pemphigus: S2 guideline for diagnosis and treatment guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).","volume":"29","author":"Hertl","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"doi200010r12","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","article-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial.","volume":"130","author":"Beissert","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"7","key":"doi200010r13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1468-3083.2011.04170.x","article-title":"Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study.","volume":"26","author":"Ioannides","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"doi200010r14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archderm.136.7.868","article-title":"Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus.","volume":"136","author":"Ioannides","year":"2000","journal-title":"Arch Dermatol"},{"issue":"1","key":"doi200010r15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archderm.1969.01610250076018","article-title":"Treatment of pemphigus vulgaris with methotrexate.","volume":"100","author":"Lever","year":"1969","journal-title":"Arch Dermatol"},{"issue":"10083","key":"doi200010r16","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"issue":"175","key":"doi200010r17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"issue":"6","key":"doi200010r18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus.","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"issue":"9","key":"doi200010r19","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archdermatol.2012.1522","article-title":"Adjuvant rituximab therapy of pemphigus: a single-center experience with 31 patients.","volume":"148","author":"Lunardon","year":"2012","journal-title":"Arch Dermatol"},{"issue":"4","key":"doi200010r20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jaad.2017.11.024","article-title":"Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center.","volume":"78","author":"Vinay","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi200010r21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/09546634.2013.784391","article-title":"Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases.","volume":"24","author":"Baum","year":"2013","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"doi200010r22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bjd.14405","article-title":"Calculation of cut-off values based on the ABSIS and PDAI pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus.","volume":"175","author":"Boulard","year":"2016","journal-title":"Br J Dermatol"},{"issue":"6","key":"doi200010r23","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus.","volume":"58","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi200010r24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jid.2018.04.042","article-title":"Large international validation of ABSIS and PDAI Pemphigus Severity Scores.","volume":"139","author":"H\u00e9bert","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"5","key":"doi200010r25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archdermatol.2009.9","article-title":"ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.","volume":"145","author":"Abasq","year":"2009","journal-title":"Arch Dermatol"},{"issue":"4","key":"doi200010r26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.annder.2019.01.018","article-title":"Update of the French recommendations for the management of pemphigus [in French].","volume":"146","author":"Jelti","year":"2019","journal-title":"Ann Dermatol Venereol"},{"issue":"2","key":"doi200010r27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2340\/00015555-1666","article-title":"Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in pemphigus patients measured by area index and intensity score.","volume":"94","author":"Patsatsi","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"12","key":"doi200010r28","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jamadermatol.2014.411","article-title":"High anti\u2013desmoglein 3 antibody ELISA index and negative indirect immunofluorescence result in a patient with pemphigus vulgaris in remission: evaluation of the antibody profile by newly developed methods.","volume":"150","author":"Nakahara","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"1","key":"doi200010r29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cei.12481","article-title":"Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study.","volume":"180","author":"Trouvin","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"doi200010r30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/art.21617","article-title":"Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis.","volume":"54","author":"Leandro","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"doi200010r31","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jaad.2017.07.012","article-title":"Developing biomarkers for predicting clinical relapse in pemphigus patients treated with rituximab.","volume":"77","author":"Albers","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi200010r32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2006.12.006","article-title":"Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis.","volume":"123","author":"Sfikakis","year":"2007","journal-title":"Clin Immunol"},{"key":"doi200010r33","article-title":"Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect (published online September 5, 2019).","author":"Chen","journal-title":"Br J Dermatol"},{"issue":"17","key":"doi200010r34","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"doi200010r35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaad.2011.11.007","article-title":"Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.","volume":"67","author":"Cianchini","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi200010r36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamadermatol.2017.5176","article-title":"Rituximab as single long-term maintenance therapy in patients with difficult-to-treat pemphigus.","volume":"154","author":"Sanchez","year":"2018","journal-title":"JAMA Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2762874\/jamadermatology_mignard_2020_oi_200010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T21:39:31Z","timestamp":1589405971000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2762874"}},"subtitle":["A Post Hoc Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.0290","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737581149.793573454","asserted-by":"object"}]},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}